RxDoctor Payments DataLook up a doctor →

ELOCTATE: payments to doctors

Payments that named ELOCTATE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$4M
Providers
314
Transactions
952
Average per transaction
$4,178

The per-transaction average — $4,178 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 314 providers the average total is $12,667, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Bioverativ Therapeutics Inc.$3,436,04086.4%
Sanofi$385,8359.7%
Swedish Orphan Biovitrum AB$97,7662.5%
Sanofi-aventis U.S. LLC$57,8201.5%
← All drugs & devices